Compare

    Two terms, side by side

    Pick any two terms to see definitions, context, pitfalls, and sources in parallel.

    Curated comparison tables

    In-depth, attribute-by-attribute tables for the most common MedTech term pairs. Each row is sourced from the linked term pages.

    Software & AI

    Model Drift Monitoring

    In one line
    Ongoing surveillance of input data and model outputs to detect performance degradation post-deployment.
    Definition
    Drift monitoring tracks data drift (input distributions changing) and concept drift (the relationship between inputs and outputs changing). For locked algorithms this triggers retraining; for adaptive algorithms it gates change-control under a PCCP. Monitoring methods include tracking input statistics against the training data, comparing outputs over time, and, where ground truth becomes available, measuring live performance metrics. Drift can come from new imaging equipment, changes in clinical practice or patient populations, or software updates in connected systems. Monitoring plans, alert thresholds and response actions should be part of post-market surveillance and documented in the device file.
    Why it matters
    FDA TPLC and PCCP guidance both expect documented drift monitoring with thresholds, alerts, and a corrective-action playbook.
    Common pitfalls
    • •Failing to define clear, measurable thresholds for drift detection can lead to ineffective monitoring and delayed corrective actions.
    • •Assuming that a "locked" algorithm negates the need for drift monitoring overlooks potential shifts in real-world data that could degrade performance.
    • •Neglecting to establish a predetermined change control plan (PCCP) for adaptive algorithms can result in regulatory non-compliance when model updates are necessary.
    • •Underestimating the resources, including personnel and infrastructure, required to effectively implement and maintain a drift monitoring program is a common pitfall.
    • •Over-reliance on automated drift detection without human oversight or expert review can lead to false positives or missed critical drift events.
    Open full page
    Select term B to compare.

    Why compare MedTech terms side by side?

    MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

    Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

    Common comparison patterns

    How to use this tool

    Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

    MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.